Oramed signs $50m oral insulin deal with China’s Hefei

Oramed Pharmaceuticals Inc., an Israeli clinical-stage company,  has signed definitive licensing and investment agreements valued at up to $50 million with Hefei Tianhui Incubator of Technologies Co.,  More...